Dhananjay Chitale
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Epigenetics and DNA Methylation 8
-
- Lung Cancer Treatments and Mutations 13
- Prostate Cancer Diagnosis and Treatment 9
- Prostate Cancer Treatment and Research 6
- Co-authors
- Marc Ladanyi (15 shared papers)Jeremy A. Squire (4 shared papers)Juan‐Sebastian Saldivar (4 shared papers)Giuseppe Giaccone (4 shared papers)David J. Kwiatkowski (4 shared papers)Robert B. Jenkins (4 shared papers)Neal I. Lindeman (4 shared papers)Sanja Đačić (4 shared papers)
- Journals
- Modern Pathology (8 papers)Cancer Research (7 papers)The Prostate (3 papers)PLoS ONE (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Dhananjay Chitale
97 papers receiving 5.3k citations
Dhananjay Chitale's Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 1.4k
- Pulmonary and Respiratory Medicine 2.5k
- Oncology 1.6k
- Pathology and Forensic Medicine 481
- Endocrinology, Diabetes and Metabolism 405
Countries citing papers authored by Dhananjay Chitale
This map shows the geographic impact of Dhananjay Chitale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dhananjay Chitale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dhananjay Chitale more than expected).
Fields of papers citing papers by Dhananjay Chitale
This network shows the impact of papers produced by Dhananjay Chitale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dhananjay Chitale. The network helps show where Dhananjay Chitale may publish in the future.
Co-authors
The 25 scholars most cited alongside Dhananjay Chitale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology Hit paper breakdown → | 2013 | 971 |
| 2 | Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma Hit paper breakdown → | 2008 | 434 |
| 3 | 2009 | 423 | |
| 4 | Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Hit paper breakdown → | 2013 | 370 |
| 5 | Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology Hit paper breakdown → | 2013 | 308 |
| 6 | 2008 | 205 | |
| 7 | 2008 | 195 | |
| 8 | 2009 | 171 | |
| 9 | 2012 | 167 | |
| 10 | 2008 | 166 | |
| 11 | 2008 | 165 | |
| 12 | 2008 | 154 | |
| 13 | 2017 | 122 | |
| 14 | 2010 | 113 | |
| 15 | 2003 | 89 | |
| 16 | Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment. | 2012 | 70 |
| 17 | False-negative core needle biopsies of the breast: An analysis of clinical, radiologic, and pathologic findings in 27 consecutive cases of missed breast cancer | 2004 | 62 |
| 18 | 2016 | 56 | |
| 19 | 2016 | 54 | |
| 20 | 2012 | 51 |
About Dhananjay Chitale
Dhananjay Chitale is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Rheumatology, having authored 105 papers that have together received 5.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (17 papers), Lung Cancer Treatments and Mutations (13 papers), Cancer Genomics and Diagnostics (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers), Breast Lesions and Carcinomas (9 papers), Epigenetics and DNA Methylation (8 papers), Prostate Cancer Treatment and Research (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Cancer Research (1.4k citations), Pulmonary and Respiratory Medicine (2.5k citations), Oncology (1.6k citations), Pathology and Forensic Medicine (481 citations) and Endocrinology, Diabetes and Metabolism (405 citations). Dhananjay Chitale has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Marc Ladanyi, Jeremy A. Squire, Juan‐Sebastian Saldivar, Giuseppe Giaccone, David J. Kwiatkowski, Robert B. Jenkins, Neal I. Lindeman, Sanja Đačić, Mary Beth Beasley and Philip T. Cagle. Their work appears in journals such as Modern Pathology, Cancer Research, The Prostate, PLoS ONE and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.